[go: up one dir, main page]

AU2001239668A1 - Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation - Google Patents

Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation

Info

Publication number
AU2001239668A1
AU2001239668A1 AU2001239668A AU3966801A AU2001239668A1 AU 2001239668 A1 AU2001239668 A1 AU 2001239668A1 AU 2001239668 A AU2001239668 A AU 2001239668A AU 3966801 A AU3966801 A AU 3966801A AU 2001239668 A1 AU2001239668 A1 AU 2001239668A1
Authority
AU
Australia
Prior art keywords
calcium
mixture
vitamin
magnesium
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239668A
Inventor
L'uboslav Razus
Petr Simek
Ivan Varga
Juraj Wendl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva KS
Original Assignee
Slovakofarma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slovakofarma AS filed Critical Slovakofarma AS
Publication of AU2001239668A1 publication Critical patent/AU2001239668A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001239668A 2000-04-06 2001-03-15 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation Abandoned AU2001239668A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SKPV498-2000 2000-04-06
SK498-2000A SK284948B6 (en) 2000-04-06 2000-04-06 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin D or mixture of calcium and magnesium in a new formulation
PCT/SK2001/000004 WO2001076610A1 (en) 2000-04-06 2001-03-15 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation

Publications (1)

Publication Number Publication Date
AU2001239668A1 true AU2001239668A1 (en) 2001-10-23

Family

ID=20435843

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239668A Abandoned AU2001239668A1 (en) 2000-04-06 2001-03-15 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation

Country Status (10)

Country Link
EP (1) EP1274447A1 (en)
AU (1) AU2001239668A1 (en)
BG (1) BG107227A (en)
CZ (1) CZ303069B6 (en)
EE (1) EE200200584A (en)
MD (1) MD2722B2 (en)
PL (1) PL357777A1 (en)
RU (1) RU2002130196A (en)
SK (1) SK284948B6 (en)
WO (1) WO2001076610A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067150B2 (en) 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
EP1758557B1 (en) 2004-05-11 2011-07-13 Egalet Ltd. Swellable dosage form comprising gellan gum
UA95093C2 (en) 2005-12-07 2011-07-11 Нікомед Фарма Ас Method for the preparation of calcium-containing compound
EP2315580B1 (en) * 2009-03-26 2011-12-28 Pulmatrix, Inc. Pharmaceutical formulations and methods for treating respiratory tract infections
ES2625260T5 (en) 2009-03-26 2020-07-29 Pulmatrix Operating Co Inc Dry powder formulations and methods for the treatment of lung diseases
WO2012030647A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
CA2812414C (en) 2010-09-29 2020-09-22 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
US20150136130A1 (en) 2012-02-29 2015-05-21 Pulmatrix, Inc. Inhalable dry powders
KR20150135328A (en) 2013-04-01 2015-12-02 풀매트릭스 인코퍼레이티드 Tiotropium dry powders
JO3456B1 (en) 2015-05-13 2020-07-05 H Lundbeck As ferrotioxetine pyroglutamate
RU2726438C2 (en) * 2018-11-14 2020-07-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Method for production of a dry high protein milk mixture for prevention of osteopenia in children and adolescents with gee's disease
CN109453126A (en) * 2018-12-07 2019-03-12 浙江核力欣健药业有限公司 A kind of calcium carbonate D3Composition of chewable tablets and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
CA1297035C (en) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Chewable, non-gritty calcium citrate tablet
US5296476A (en) * 1989-09-08 1994-03-22 Henderson Esther G Skin care compositions
WO1994014458A1 (en) * 1992-12-23 1994-07-07 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US6241997B1 (en) * 1998-03-16 2001-06-05 Smtm Group. Llc Chewable calcium supplement and method

Also Published As

Publication number Publication date
EP1274447A1 (en) 2003-01-15
PL357777A1 (en) 2004-07-26
WO2001076610A1 (en) 2001-10-18
CZ303069B6 (en) 2012-03-21
MD2722B2 (en) 2005-03-31
BG107227A (en) 2003-05-30
SK4982000A3 (en) 2001-10-08
MD20020265A (en) 2003-05-31
RU2002130196A (en) 2004-03-27
EE200200584A (en) 2004-04-15
SK284948B6 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
HUP0303434A3 (en) Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium
AU2635201A (en) Direct manipulation of displayed content
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
AU7645701A (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HUS1400025I1 (en) Phenethanolamine derivatives and pharmaceutical composition containing them
WO2003007802A3 (en) Pharmaceutical combinations of oxycodone and naloxone
AU2001239668A1 (en) Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation
DZ3313A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HU9901570D0 (en) Use of nanodispersions in pharmaceutical compositions
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
AU4303600A (en) Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
AU2002229616A1 (en) Improvements in and relating to the distribution of content
AU2001230902A1 (en) Slow-release insect-repellent composition and uses
HUP0300539A3 (en) New pharmaceutical composition in form of emulsion preconcentrate
AU2002225527A1 (en) Powdered fat composition and products made thereof
AU2001275821A1 (en) Anti-cancer composition composed of anti-cancer and anti-malarial drugs
PL362965A1 (en) Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
AU2001252741A1 (en) Pharmaceutical composition containing itraconazole with gastric ph-independentlyimproved solubility and preparation method thereof
AU2511997A (en) Composition containing milnacipran and idazoxan for use as combined pharmaceutical preparation
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
AU2002240949A1 (en) Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy
AU2002212327A1 (en) Pharmaceutical preparation comprised of milk-thistle and terpenes